Cargando…

High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection

This study independently confirms increased levels of osteopontin in COVID‐19 patients but also suggests that osteopontin cannot be used as a biomarker of SARS‐CoV‐2 infection, as elevated levels of circulating osteopontin are found in inflammatory lung disease regardless of SARS‐CoV‐2 infection.[Im...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappellano, Giuseppe, Abreu, Hugo, Raineri, Davide, Scotti, Lorenza, Castello, Luigi, Vaschetto, Rosanna, Chiocchetti, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103078/
https://www.ncbi.nlm.nih.gov/pubmed/33787012
http://dx.doi.org/10.15252/emmm.202114124
_version_ 1783689243486322688
author Cappellano, Giuseppe
Abreu, Hugo
Raineri, Davide
Scotti, Lorenza
Castello, Luigi
Vaschetto, Rosanna
Chiocchetti, Annalisa
author_facet Cappellano, Giuseppe
Abreu, Hugo
Raineri, Davide
Scotti, Lorenza
Castello, Luigi
Vaschetto, Rosanna
Chiocchetti, Annalisa
author_sort Cappellano, Giuseppe
collection PubMed
description This study independently confirms increased levels of osteopontin in COVID‐19 patients but also suggests that osteopontin cannot be used as a biomarker of SARS‐CoV‐2 infection, as elevated levels of circulating osteopontin are found in inflammatory lung disease regardless of SARS‐CoV‐2 infection.[Image: see text]
format Online
Article
Text
id pubmed-8103078
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81030782021-05-10 High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection Cappellano, Giuseppe Abreu, Hugo Raineri, Davide Scotti, Lorenza Castello, Luigi Vaschetto, Rosanna Chiocchetti, Annalisa EMBO Mol Med Correspondence This study independently confirms increased levels of osteopontin in COVID‐19 patients but also suggests that osteopontin cannot be used as a biomarker of SARS‐CoV‐2 infection, as elevated levels of circulating osteopontin are found in inflammatory lung disease regardless of SARS‐CoV‐2 infection.[Image: see text] John Wiley and Sons Inc. 2021-03-31 2021-05-07 /pmc/articles/PMC8103078/ /pubmed/33787012 http://dx.doi.org/10.15252/emmm.202114124 Text en © 2021 The Authors. Published under the terms of the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Cappellano, Giuseppe
Abreu, Hugo
Raineri, Davide
Scotti, Lorenza
Castello, Luigi
Vaschetto, Rosanna
Chiocchetti, Annalisa
High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
title High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
title_full High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
title_fullStr High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
title_full_unstemmed High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
title_short High levels of circulating osteopontin in inflammatory lung disease regardless of Sars‐CoV‐2 infection
title_sort high levels of circulating osteopontin in inflammatory lung disease regardless of sars‐cov‐2 infection
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103078/
https://www.ncbi.nlm.nih.gov/pubmed/33787012
http://dx.doi.org/10.15252/emmm.202114124
work_keys_str_mv AT cappellanogiuseppe highlevelsofcirculatingosteopontinininflammatorylungdiseaseregardlessofsarscov2infection
AT abreuhugo highlevelsofcirculatingosteopontinininflammatorylungdiseaseregardlessofsarscov2infection
AT raineridavide highlevelsofcirculatingosteopontinininflammatorylungdiseaseregardlessofsarscov2infection
AT scottilorenza highlevelsofcirculatingosteopontinininflammatorylungdiseaseregardlessofsarscov2infection
AT castelloluigi highlevelsofcirculatingosteopontinininflammatorylungdiseaseregardlessofsarscov2infection
AT vaschettorosanna highlevelsofcirculatingosteopontinininflammatorylungdiseaseregardlessofsarscov2infection
AT chiocchettiannalisa highlevelsofcirculatingosteopontinininflammatorylungdiseaseregardlessofsarscov2infection